Menu Close

Trending

Measuring the cost-effectiveness of vaccines targeting infectious diseases
Could your loyalty card help spot cancer? Study says yes
JP Morgan 2023 – Adi Hoess
Tackling ongoing staffing burnout rates through AI-enabled precision oncology
Ipsen’s rare disease drug palovarotene knocked back in EU

Insights

pharmaphorum_podcast-Episode-73

Digital/ Healthcare/ Insights/ Insights/ Insights/ Insights/ Market Access/ Oncology/ Patients/ Pharma Market Access/ Podcast/ R&D/ Sales and Marketing/ Transversal Categories/ Video/ Views and analysis

A few of 2022’s biggest pharma trends – the pharmaphorum podcast

, , , , , , , , , , 0 Comment

As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some

X
A few of 2022’s biggest pharma trends – the pharmaphorum podcast
https://pharmaphorum.com/podcast/a-few-of-2022s-biggest-pharma-trends/
long term market data

Insights/ Market Access/ Views & Analysis/ Views and analysis

Is the launch environment really more competitive now?

, , , , , 0 Comment

It’s often stated – mostly without reference to data – that the environment for innovative launches is more

X
Is the launch environment really more competitive now?
https://pharmaphorum.com/views-and-analysis/is-the-launch-environment-really-more-competitive-now/
IQVIA - RWE paper masthead 18

Insights/ Market Access/ Pharma Market Access/ Quintiles - Oncol articles/ White Papers/ Whitepapers

Standing on the cusp of something great: How real-world data is poised to transform cancer care

, , , , , , 0 Comment

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care How can real world evidence (RWE) improve the

X
Standing on the cusp of something great: How real-world data is poised to transform cancer care
https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/
P_and_MA_IMG_840x470

Insights/ Insights/ Market Access/ Pharma Market Access/ R&D/ Slider in whitepapers/ White Papers/ Whitepapers

Pricing and market access – facts versus fiction

0 Comment

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

X
Pricing and market access – facts versus fiction
https://pharmaphorum.com/whitepapers/pricing-market-access-facts-versus-fiction/

Digital/ Digital and Social Media/ Insights/ Insights/ Market Access/ Sales and Marketing/ White Papers/ Whitepapers

Big data in Life Sciences: the time for strategy is now

, , , 0 Comment

The ability to extract insights from big data is quickly becoming a key factor for competitive advantage in

X
Big data in Life Sciences: the time for strategy is now
https://pharmaphorum.com/whitepapers/life-sciences-brands-need-big-data-strategy-now/

Insights/ Market Access/ Pharma Market Access/ White Papers/ Whitepapers

Next-generation brand launches: Global health data and insights can transform your business

0 Comment

Life Sciences companies face challenges today in achieving their revenue forecast and return on investment from brand launches. Much

X
Next-generation brand launches: Global health data and insights can transform your business
https://pharmaphorum.com/whitepapers/next-generation-brand-launches-global-health-data-and-insights-can-transform-your-business/
1 2

Login

CONTINUE TO SITE >
X
Close in 10 seconds